The subrenal capsule assay in mice. Prediction of rat tumor sensitivity to chemotherapy
- 15 October 1984
- Vol. 54 (8) , 1530-1534
- https://doi.org/10.1002/1097-0142(19841015)54:8<1530::aid-cncr2820540810>3.0.co;2-x
Abstract
The predictive value of the subrenal capsule (SRC) assay for cancer chemotherapy was tested in five rat tumors. Tumor-bearing rats were used as controls. In order to simulate clinical chemotherapy, different dose regimens and drug combinations were used. All five tumors were evaluable in the SRC assay. Taking into account cytotoxic drugs, 86% compatibility was obtained between the SRC assay and the rat model. Antitumor effect of three antiestrogenic compounds could not be predicted by the SRC assay. It is concluded that the SRC assay can be expected to have predictive value in the assessment of tumor sensitivity to single and combination chemotherapy based on experimental animal models.This publication has 9 references indexed in Scilit:
- Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyCancer, 1983
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Cancer drug sensitivity test has problemsPublished by American Medical Association (AMA) ,1982
- In vitro short-term test to determine the resistance of human tumors to chemotherapyCancer, 1981
- Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: Six-day subrenal capsule assayCancer, 1981
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- Response of Endometrioid Ovarian Carcinoma in Nude Mice to the Combination of Vincristine Sulphate and CyclophosphamideActa Obstetricia et Gynecologica Scandinavica, 1980
- Growth of Human Tumor Xenografts Implanted under the Renal Capsule of Normal Immunocompetent MicePathobiology, 1979
- Heterotransplantation of human cancers into nude mice. A model system for human cancer chemotherapyCancer, 1978